Identification of N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB), an homologue derivative of "ecstasy"

Citation
P. Baudot et al., Identification of N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB), an homologue derivative of "ecstasy", ANALUSIS, 27(6), 1999, pp. 523-532
Citations number
38
Categorie Soggetti
Spectroscopy /Instrumentation/Analytical Sciences
Journal title
ANALUSIS
ISSN journal
03654877 → ACNP
Volume
27
Issue
6
Year of publication
1999
Pages
523 - 532
Database
ISI
SICI code
0365-4877(199907/08)27:6<523:ION(A>2.0.ZU;2-I
Abstract
Some of the various N-substituted derivatives of the MDA have become popula r drugs of abuse (MDMA, MDEA) in Europe and in France. With the increasing seizures of MBDB, [N-methyl-1-(1,3-bznzodioxol-5-yl)-2-butanamine] a new ho mologue of MDMA and MDEA, forensic analysis of these controlled substances requires the use of powerful techniques to char characterize them. Analysis by either high performance liquid chromatography (HPLC) or capillary gas c hromatography (CGC) allows the separation of MDMA, MDEA, MBDB and EBDB. The isomers MDEA and MBDB are best differentiated by either nuclear magnetic r esonance spectroscopy (H-1-NMR) or the combination of mass spectra (MS) and retention time (CGC). These techniques were successfully applied to seized tablets.